Related Experiment Video
Updated: Nov 6, 2025

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging
Published on: September 12, 2025
The Relationship between Mucins and Ulcerative Colitis: A Systematic Review.
Esther Bankole1, Emily Read1, Michael A Curtis1
1Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Science, King's College London, London SE1 9RT, UK.
Mucins, key mucus components, show altered activity in ulcerative colitis (UC) patients. This systematic review highlights the impact of MUC2 changes on the colon, emphasizing the need for further UC research.
Area of Science:
- Gastroenterology
- Molecular Biology
- Immunology
Background:
- Mucins are vital for mucosal barrier function.
- Ulcerative colitis (UC), an inflammatory bowel disease (IBD), involves colonic inflammation.
- Mucin alterations may contribute to UC pathogenesis.
Purpose of the Study:
- To systematically review existing data on mucin activity in UC patients.
- To determine if mucin alterations are present in the colonic mucosa of UC patients.
Main Methods:
- Systematic literature search (1990-2020) for studies on mucins in UC.
- Inclusion of studies with UC patient biopsy analysis and control groups.
- Critical review of 16 selected studies, with 13 focusing on MUC2.
Main Results:
- The majority of reviewed studies suggest MUC2 alterations impact the colonic mucosa in UC.
- Conflicting results were noted regarding MUC2 expression levels in UC.
- Data indicates a significant role for mucins in UC pathophysiology.
Conclusions:
- Further research is crucial to fully understand mucin regulation in UC.
- Findings underscore the importance of mucins in maintaining gut health and UC development.
- This review provides a foundation for future investigations into mucin-targeted UC therapies.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

